GILD

Gilead Sciences, Inc. News Headlines

$100.79
*  
0.49
0.48%
Get GILD Alerts
*Delayed - data as of Aug. 20, 2014  -  Find a broker to begin trading GILD now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Emergent BioSolutions, MorphoSys Tie Up on Cancer Candidate - Analyst Blog
8/20/2014 6:08:00 PM - Zacks.com

3 Reasons Gilead Science, Inc.’s Stock Could Rise
8/20/2014 5:36:21 PM - Motley Fool

Hospira Sues FDA on Generic Precedex Approval, Shares Down - Analyst Blog
8/20/2014 5:00:00 PM - Zacks.com

Healthcare Enjoys Growth Trends: 3 Medical Stocks to Buy - Analyst Blog
8/20/2014 4:27:00 PM - Zacks.com

Oncothyreon (ONTY) Slumps, Tecemotide Fails Phase I/II Study - Analyst Blog
8/20/2014 3:53:00 PM - Zacks.com

Determining Gilead's Fair Value
8/20/2014 2:51:00 PM - Seeking Alpha

Record Earnings & Stronger Growth in Q2 - Earnings Outlook
8/20/2014 3:57:00 AM - Zacks.com

Record Earnings & Stronger Growth in Q2 - Earnings Trends
8/20/2014 3:57:00 AM - Zacks.com

Will Roche (RHHBY) Buy the Remaining Stake in Chugai? - Analyst Blog
8/19/2014 5:55:00 PM - Zacks.com

Amgen (AMGN) Reports Encouraging Top-Line Data on AMG 416 - Analyst Blog
8/19/2014 5:25:00 PM - Zacks.com

After Hours Most Active for Aug 19, 2014 : BAC, XOM, AAPL, QQQ, MET, MSFT, NOK, CAT, BBD, MDLZ, GILD, ACHN
8/19/2014 4:44:45 PM - NASDAQ.com News

Pfizer Submits Palbociclib Marketing Application to the FDA - Analyst Blog
8/19/2014 4:20:00 PM - Zacks.com

Record Earnings & Stronger Growth in Q2 - Earnings Trends
8/19/2014 2:57:00 PM - Investopedia

Biogen Strengthens MS Portfolio with Plegridy FDA Approval - Analyst Blog
8/19/2014 1:20:00 PM - Zacks.com

Gilead Beats Apple To $100. Who Will Win Race To $120?
8/19/2014 1:09:00 PM - Seeking Alpha

PDL BioPharma Misses on Q2 Earnings due to Higher Expenses - Analyst Blog
8/19/2014 9:10:00 AM - Zacks.com

Celladon Corp. (CLDN) Jumps: Stock Adds 11.3% in Session - Tale of the Tape
8/19/2014 8:51:00 AM - Zacks.com

Achillion Pharmaceuticals Soars on Mid-Stage HCV Study Data - Analyst Blog
8/18/2014 4:45:00 PM - Zacks.com

Should Achillion Pharma (ACHN) Be In Your Portfolio Now? - Stocks in the News
8/18/2014 3:20:06 PM - Zacks.com

Gilead Scores Legal Victory Over Roche for Sovaldi, Shares Up - Analyst Blog
8/18/2014 1:34:00 PM - Zacks.com

Jim Cramer Answers Twitter (TWTR) Questions on Walmart (WMT), Yelp (YELP), Kinder Morgan (KMI) and More
8/18/2014 12:40:00 PM - TheStreet

3 Big Stocks on Traders' Radars
8/18/2014 12:02:00 PM - TheStreet

Techne Corporation (TECH) Ex-Dividend Date Scheduled for August 19, 2014
8/18/2014 9:00:01 AM - NASDAQ.com News

#PreMarket Primer: Monday, August 18: Jackson Hole Draws Market Attention
8/18/2014 7:12:40 AM - Benzinga

Why Gilead Is The Most Exciting Growth Opportunity In 2014
8/15/2014 5:10:00 PM - Seeking Alpha